Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuzatrelvir pharmacokinetics in healthy Chinese adults
NCT07235137Phase 1Completed
- Sponsor
- Pfizer
- Start
- Oct 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ibuzatrelvir, sponsored by Pfizer. Primary endpoints: Maximum Observed Plasma Concentration at 3 days, Area Under the Curve from Time Zero to Infinity at 3 days and 1 more. Started Oct 2025; status: completed.
02
Drugs
ibuzatrelvir
Beyond the preview
Go deeper on NCT07235137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07235137.